All News

A new report from the United States Government Accountability Office is calling for pharmacy systems to better serve veterans through additional capabilities for viewing, exchanging, and using data.

The Duke Center for Health Data Science was in the planning stages before Robert Califf, MD, departed for a stint as FDA commissioner.

The Supreme Court of the United States has determined that a group of nonresident plaintiffs may not sue Bristol-Myers Squibb (BMS) in California state court, as neither these patients nor the pharmaceutical company reside in that state. The ruling could have important implications for lawsuits seeking compensation for alleged harms.

A collaborative study among scientists working across 3 continents has found a strong association between circulating free DNA in patients being treated with olaparib (Lynparza) for prostate cancer and disease outcome.

The new law includes requirements that drugmakers reveal discounts for pharmacy benefit managers and prevents gag rules on pharmacists who want to suggest cheaper alternatives.

As the opioid epidemic continues across America, medication-assisted therapies, like buprenorphine or naltrexone, have been highlighted as an important tool. However, a new study indicates that the number of young people with opioid use disorder who actually receive these medications remains low, although it has increased since 2001.

Young adult cancer survivors face an uncertain path to parenthood-here is one story.

Experts hoped that Medicaid expansion would direct the previously uninsured into primary care and reduce reliance on the emergency department. What happened is more complicated.

The European Commission has approved Rixathon, a biosimilar of the cancer drug rituximab, for use in Europe, according to an announcement from Novartis, whose Sandoz division manufactures the biosimilar.

For caregivers to use data properly, they must understand that much of the actionable data lives outside the healthcare system.

States should maintain laws and policies to regulate cost-sharing in private health insurance because of the barrier it creates between the consumer and health services, reveals a recent report.

Patients with rheumatoid arthritis with high multi-biomarker disease activity scores have an increased risk of radiographic progression, according to a new analysis of 6 different studies.

New data has demonstrated an association between high Vectra DA scores and an increased risk of joint damage progression in patients with rheumatoid arthritis.

Hybrid closed-loop insulin delivery systems, also called an “artificial pancreas,” have attracted a great deal of attention since the FDA approved the first such device last September. These systems continuously monitor blood glucose levels and adjust insulin dosing accordingly, although they require some input from users around mealtimes.

Staff at mental health hospitals have long believed that tobacco helped calm patients, when in fact the nicotine only covered symptoms of withdrawal.

This week, the top managed care news included a report from CMS that found 2 million people dropped Obamacare coverage after failing to pay their premiums; a study found the diabetes drug canagliflozin reduced cardiovascular risk; and the Supreme Court of the United States rules in favor of biosimilars.

At the 8th Annual Oncology Market Access & Pricing USA 2017 meeting hosted by eyeforpharma, pharmaceutical developers shared strategies on how a “value” culture can be infused right from the preclinical stage of oncology product development.

Cardiovascular outcomes trials and a photography ban that dominated social media were big news at the 77th Scientific Sessions of the American Diabetes Association.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Guidelines recommend against screening for cancer in patients with shortened life expectancy, but a recent study revealed older patients may not want to consider their life expectancy when discussing with a clinician whether they should stop undergoing cancer screening.

The researchers' approach to finding the compound could be used to find cures in other diseases.

Although the country is moving toward value-based payments, for providers it’s basically still a fee-for-service world, said Charles J. Fazio, MD, MS, of HealthPartners Health Plan, at America’s Health Insurance Plans’ Institute & Expo, held June 9-10 in Austin, Texas.

State-level decisions on whether to expand Medicaid had ripple effects across the rest of the healthcare insurance market, according to a report by the Office of the CMS Actuary in Health Affairs.

On June 14, 2017, The Institute for Clinical and Economic Review (ICER) added a “New Evidence Update” to the 2015 review of the comparative clinical effectiveness and value of PCSK9 inhibitors for management of high cholesterol.

On June 14, 2017, Western Connecticut Health Network (WCHN) announced its launch of a new study that will research the connection between pancreatic cancer and new-onset diabetes. This $2.7 million study will span 3 years and aims to discover a method to detect pancreatic cancer while it can still be cured.

A meta-analysis spearheaded by The International Testicular Cancer Consortium has identified new susceptibility loci in the human genome that can increase a person’s risk of developing inherited testicular germ cell tumors.